Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression - PubMed (original) (raw)
Comparative Study
. 1993 May 7;73(3):585-96.
doi: 10.1016/0092-8674(93)90144-f.
Affiliations
- PMID: 8387896
- DOI: 10.1016/0092-8674(93)90144-f
Comparative Study
Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression
J Kunz et al. Cell. 1993.
Abstract
The yeast TOR2 gene encodes an essential 282 kd phosphatidylinositol (PI) 3-kinase homolog. TOR2 is related to the catalytic subunit of bovine PI 3-kinase and to yeast VPS34, a vacuolar sorting protein also shown to have PI 3-kinase activity. The immunosuppressant rapamycin most likely acts by inhibiting PI kinase activity because TOR2 mutations confer resistance to rapamycin and because a TOR1 TOR2 double disruption (TOR1 is a nonessential TOR2 homolog) confers G1 arrest, as does rapamycin. Our results further suggest that 3-phosphorylated phosphoinositides, whose physiological significance has not been determined, are an important signal in cell cycle activation. In yeast, this signal may act in a signal transduction pathway similar to the interleukin-2 signal transduction pathway in T cells.
Similar articles
- TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast.
Helliwell SB, Wagner P, Kunz J, Deuter-Reinhard M, Henriquez R, Hall MN. Helliwell SB, et al. Mol Biol Cell. 1994 Jan;5(1):105-18. doi: 10.1091/mbc.5.1.105. Mol Biol Cell. 1994. PMID: 8186460 Free PMC article. - FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity.
Cardenas ME, Heitman J. Cardenas ME, et al. EMBO J. 1995 Dec 1;14(23):5892-907. doi: 10.1002/j.1460-2075.1995.tb00277.x. EMBO J. 1995. PMID: 8846782 Free PMC article. - Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity.
Cafferkey R, Young PR, McLaughlin MM, Bergsma DJ, Koltin Y, Sathe GM, Faucette L, Eng WK, Johnson RK, Livi GP. Cafferkey R, et al. Mol Cell Biol. 1993 Oct;13(10):6012-23. doi: 10.1128/mcb.13.10.6012-6023.1993. Mol Cell Biol. 1993. PMID: 8413204 Free PMC article. - Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.
Wiederrecht GJ, Sabers CJ, Brunn GJ, Martin MM, Dumont FJ, Abraham RT. Wiederrecht GJ, et al. Prog Cell Cycle Res. 1995;1:53-71. doi: 10.1007/978-1-4615-1809-9_5. Prog Cell Cycle Res. 1995. PMID: 9552353 Review. - Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling.
Abraham RT. Abraham RT. Curr Opin Immunol. 1998 Jun;10(3):330-6. doi: 10.1016/s0952-7915(98)80172-6. Curr Opin Immunol. 1998. PMID: 9638370 Review.
Cited by
- mTOR Signaling: Roles in Hepatitis B Virus Infection and Hepatocellular Carcinoma.
Mei L, Sun H, Yan Y, Ji H, Su Q, Chang L, Wang L. Mei L, et al. Int J Biol Sci. 2024 Aug 1;20(11):4178-4189. doi: 10.7150/ijbs.95894. eCollection 2024. Int J Biol Sci. 2024. PMID: 39247820 Free PMC article. Review. - Amino acids TORC (talk) to anabolism through uncharged tRNA.
Ma ZZ, Zhao SM. Ma ZZ, et al. Sci China Life Sci. 2024 Aug;67(8):1775-1776. doi: 10.1007/s11427-023-2575-1. Epub 2024 Apr 30. Sci China Life Sci. 2024. PMID: 38703347 No abstract available. - Structure-based engineering of Tor complexes reveals that two types of yeast TORC1 produce distinct phenotypes.
Kamada Y, Umeda C, Mukai Y, Ohtsuka H, Otsubo Y, Yamashita A, Kosugi T. Kamada Y, et al. J Cell Sci. 2024 Feb 15;137(4):jcs261625. doi: 10.1242/jcs.261625. Epub 2024 Feb 28. J Cell Sci. 2024. PMID: 38415789 Free PMC article. - Advances in the regulatory mechanisms of mTOR in necroptosis.
Xie Y, Zhao G, Lei X, Cui N, Wang H. Xie Y, et al. Front Immunol. 2023 Dec 18;14:1297408. doi: 10.3389/fimmu.2023.1297408. eCollection 2023. Front Immunol. 2023. PMID: 38164133 Free PMC article. Review. - Look who's TORking: mTOR-mediated integration of cell status and external signals during limb development and endochondral bone growth.
H'ng CH, Khaladkar A, Rosello-Diez A. H'ng CH, et al. Front Cell Dev Biol. 2023 Apr 19;11:1153473. doi: 10.3389/fcell.2023.1153473. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37152288 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous